Both in Pharmaceuticals
Contineum Therapeutics vs Opus Genetics
Over the past year CTNM returned −20.3% and IRD returned +72.0%; their daily moves had a correlation of 0.20.
CTNM −20.3% IRD +72.0%Growth of $1, one year, split-adjusted
| Metric | CTNM | IRD |
|---|---|---|
| Price | $8.94 | $3.44 |
| Market cap | $336.1M | $286.2M |
| Today | +9.77% | +3.61% |
| 1 month | −29.8% | −31.9% |
| 6 months | −28.7% | −31.2% |
| Year to date | −21.8% | +71.1% |
| 1 year | −19.1% | +72.9% |
| Revenue growth (YoY) | — | −73.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1072.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 29.0× |
| Net cash | $236.6M | $53.9M |
| Dividend yield | — | — |
| Volatility (60d) | 117.2% | 91.1% |
| Short % of float | 13.1% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).